Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-29.30	159.36	225.41
Graham Fair Price	-35.91	3.86	6.03
PEG	847.11	-0.92	0.10
Price/Book	-8.21	16.99	18.51
Price/Cash Flow	-61.10	78.62	202.08
Prices/Earnings	147.16	56.29	22.77
Price/Sales	-11.00	46.87	52.66
Price/FCF	-61.10	78.62	202.08
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.09	0.79	0.78
Operating Margin	81.91	0.27	0.15
ROA	-61.24	0.02	0.05
ROE	0.20	0.08	-62.86
ROIC	0.24	0.03	-87.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.06	-0.04	-60.64
Dividends QOQ	< 0.005	0.21	11896.26
EBIT QOQ	-0.37	0.98	165.99
EPS QOQ	2.35	-0.61	-73.90
FCF QOQ	0.24	1.49	514.05
Revenue QOQ	0.01	0.09	564.44
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	85.04	73.14	-14.00
Inventory Turnover	67797000.00	0.00	inf
Debt/Capitalization	0.64	0.61	-4.27
Quick Ratio	0.48	0.50	4.33
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.82	2.97	5.16
Cash	0.22	0.45	106.48
Capex	-0.02	-0.01	41.11
Free Cash Flow	0.26	0.64	148.13
Revenue	0.99	1.07	8.47
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.55	0.57	2.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	18.96	12.38	-34.68
Naive Interpretation	Member

06 - Financial Health · Bad

Rating